Enel Health®Atlas
Sign in
Enel Health®Atlas
Browse libraries

Not medical advice. The Atlas is not a substitute for a clinician who can examine you.

The WADA Framework and Therapeutic Use Exemptions

How Athletes Navigate Testosterone Under Anti-Doping Rules

Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.

The written rationale for this grade is still being prepared.

FDA
Not an FDA matter; governed by WADA Code
WADA
Prohibited (S1 Anabolic Agent), in and out of competition

Reference only. Not medical advice.

What can go wrong

An athlete who takes testosterone without a valid TUE commits an anti-doping rule violation, with sanctions up to multi-year bans. Even with a clinical indication, a TUE is not guaranteed. Athletes should never assume a physician's TRT prescription protects them under the WADA Code.

This is something to take to a clinician. The Atlas can tell you what is known about the wada framework and therapeutic use exemptions in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.

Under the World Anti-Doping Agency (WADA) Code, testosterone and other anabolic-androgenic steroids sit in category S1 of the Prohibited List and are banned both in and out of competition. An athlete who medically needs a prohibited substance must obtain a Therapeutic Use Exemption (TUE), governed by the International Standard for Therapeutic Use Exemptions (ISTUE). For testosterone, TUEs are granted very restrictively, generally only for documented organic (structural/genetic) hypogonadism, not age-related or functional low testosterone, and not for prior steroid abuse.

For an elite athlete, testosterone is banned at all times, a TUE is the only legal door, and it rarely opens.

What people take it for

What it is taken for. Approval, where it exists, covers only some of these.

  • Governs whether an athlete on TRT may compete
  • Defines the TUE application process
  • Sets criteria distinguishing legitimate medical need from doping

How it works

A TUE must satisfy ISTUE criteria, broadly: the athlete would experience significant health impairment without the substance; its therapeutic use would not produce additional performance enhancement beyond a return to normal health; there is no reasonable permitted alternative; and the need is not the result of prior non-therapeutic use of a prohibited substance. For testosterone these criteria are stringent because exogenous T inherently confers performance benefit, making the 'no additional enhancement' condition hard to meet outside true clinical deficiency.

Why most low-T men could never get a competition TUE

The marketplace framing of TRT, 'optimize' an aging man's testosterone, collides directly with anti-doping logic. WADA distinguishes organic hypogonadism (a structural or genetic failure of the testes or pituitary) from functional hypogonadism (low T driven by obesity, aging, or stress). The latter, which describes most direct-to-consumer TRT candidates, generally does not qualify for a TUE, and prior anabolic steroid use universally disqualifies an application. An athlete starting marketplace TRT could therefore become ineligible to compete.

What people get wrong

  • Often saidA doctor's TRT prescription lets an athlete compete

    ActuallyNo, only a valid TUE granted under ISTUE does, and testosterone TUEs are rarely granted outside organic hypogonadism.

  • Often saidEsters are a loophole

    ActuallyWADA explicitly prohibits the esters of anabolic agents (cypionate, enanthate, propionate, etc.).

Who profits, and who pushes back

Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.

At a glance

Governing body
World Anti-Doping Agency (WADA)
Category
S1 Anabolic Agents (Prohibited List)
Scope
Prohibited at all times (in- and out-of-competition)
Exemption standard
International Standard for TUEs (ISTUE)
TUE for T
Generally only organic hypogonadism; functional/age-related typically denied

What this entry does not yet cover

What follows is unfinished work on our side, not a finding about The WADA Framework and Therapeutic Use Exemptions. A short entry is not a safe entry.

  • Timeline. We have not built the dated record of research and regulatory events.
  • Cost and market. We have not documented what it sells for or who sells it.
  • Supply chain. We have not mapped where it is made.
  • Who uses it. We have not documented the user groups.
  • What could change. No forward-looking summary yet.
  • How it compares. We have not set it against the alternatives.
  • Children and teenagers. We have not checked what is known about younger people.

Sources

The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.

The studies that matter

  • International Standard for TUEs (ISTUE)ongoing

    Defines harmonized criteria for granting exemptions across sports and countries

  • WADA Prohibited List, S1annual

    Lists testosterone and its esters as prohibited anabolic agents at all times